- Single Room System
- Multi-Room System
Proton Therapy Market size was valued at USD 454.14 million in 2022 and is expected to reach USD 1,084.90 million by 2029 at a CAGR of 11.5% during the forecast period 2023-2029. Proton therapy is also known as proton beam radiation therapy. Proton is a positively charged particle, and in high energy levels, protons can destroy cancer cells. Proton therapy is a non-invasive procedure in which proton radiation is used to treat cancer. Proton therapy is a type of external beam radiation therapy, that painlessly delivers radiation through the skin from outside of the body. For the treatment of cancer, proton therapy may be prescribed alone or along with other treatments such as surgery, chemotherapy, general radiation therapy, and or immunotherapy. The global proton therapy market is expected to grow at significant CAGR rates during the forecast period owing to factors such as the growing prevalence of cancer and the adaptation of non-invasive techniques such as radiation therapy to treat the cancer tumors.
Fastest Growing Market
Global proton therapy market is mainly driven by an increase in the adaptation of non-invasive therapies in the treatment of cancer. In addition, growing number of radiation centers globally coupled with the increase in the prevalence of the cancer cases expected to fuel the market growth over the forecast period. Furthermore, proton therapy is more advantageous than the other radiation therapies. Proton therapy delivers up to 60% less radiation to healthy tissue around the tumor and has fewer side effects during and after the treatment. Based on above-mentioned factors global proton therapy market is expected to increase its traction over the forecast period. However, a high cost of proton radiation therapy and stringent regulatory procedures may hamper the global proton therapy market over the forecast period.
The proton therapy market size was valued at USD 454.14 million in 2022
The proton therapy market's key players are: Ion Beam Applications Provision Healthcare Hitachi Ltd. Mevion Medical Systems Optivus Proton Therapy Inc. Pronova Solutions Llc. Sumitomo Corporation Siemens Ltd Mirion Technologies Toshiba Corp.
The proton therapy market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.